Chargement en cours...
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
Poison inhibitors of DNA topoisomerase II (TOP2) are clinically used drugs that cause cancer cell death by inducing DNA damage, which mechanism of action is also associated with serious side effects such as secondary malignancy and cardiotoxicity. In contrast, TOP2 catalytic inhibitors induce limite...
Enregistré dans:
| Publié dans: | Front Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883873/ https://ncbi.nlm.nih.gov/pubmed/33598437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.633142 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|